| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue | 263,440 | 262,747 | 235,587 | | Cost of Revenue | 121,571 | 110,866 | 93,517 | | | Gross Profit | 141,869 | 151,881 | 142,070 | | | Operating Expenses | | Research Development | 43,107 | 41,069 | 40,039 | | Selling General and Administrative | 106,788 | 104,475 | 93,519 | | Non Recurring | 14,406 |
-
|
-
| | Others | 734 | 749 | 365 | | | | Total Operating Expenses | 165,035 |
-
|
-
| | | | Operating Income or Loss | (23,166) | 5,588 | 8,147 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,677 | 1,523 | 4,407 | | Earnings Before Interest And Taxes | (21,489) | 7,111 | 12,554 | | Interest Expense | 1,245 | 1,362 | 1,116 | | Income Before Tax | (22,734) | 5,749 | 11,438 | | Income Tax Expense | 361 | 333 | 3,805 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (23,095) | 5,416 | 7,633 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (23,095) | 5,416 | 7,633 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($23,095) | $5,416 | $7,633 |
|
1.48% Nasdaq 
Income Statement
